BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7535460)

  • 1. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
    Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
    Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy.
    Lee WJ; Zimmerman T; Meyers S; Bender JG; Williams SF
    Prog Clin Biol Res; 1994; 389():421-7. PubMed ID: 7535451
    [No Abstract]   [Full Text] [Related]  

  • 3. Single dose of filgrastim (rhG-CSF) to predict mobilisation of haemopoietic progenitors in patients with haematological malignancies.
    Mijovic A; Mufti GJ
    Bone Marrow Transplant; 1995 May; 15(5):813-4. PubMed ID: 7545491
    [No Abstract]   [Full Text] [Related]  

  • 4. Yield of primed progenitor cells as determined by days of priming with recombinant human granulocyte-colony stimulating factor.
    Ericson SG; Meehan KR; Tosteson TD; Mills LE
    Prog Clin Biol Res; 1994; 389():449-55. PubMed ID: 7535453
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative assessment of colony growth and hematologic engraftment in patients undergoing high-dose chemotherapy and autologous bone marrow transplantation for breast cancer.
    Meehan KR; Ericson SG; Tosteson TD; Mills LE
    Prog Clin Biol Res; 1994; 389():497-503. PubMed ID: 7535459
    [No Abstract]   [Full Text] [Related]  

  • 6. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective comparison of three different methods for mobilization of peripheral blood stem cells.
    Mangan KF; Mullaney MT; Klumpp TR; Goldberg SL; Macdonald JS
    Prog Clin Biol Res; 1994; 389():441-8. PubMed ID: 7535452
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
    Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
    Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group].
    Brunet S; Urbano-Ispizua A; Solano C; Ojeda E; Caballero D; Torrabadella M; de la Rubia J; Pérez-Oteiza J; Moraleda J; Espigado I; de la Serna J; Petit J; Bargay J; Mataix R; Vivancos P; Figuera A; Sierra J; Domingo-Albós A; Hernández F; García Conde J; Rozman C
    Sangre (Barc); 1997 Apr; 42 Suppl 1():42-3. PubMed ID: 9381301
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined therapy with rG-CSF and GM-CSF for the mobilization of hematopoietic progenitor cells.
    Winter JN; Mangan C; Bryd K; Tallman M; Gordon L; Jahnke L; Lazarus H; Cooper B; Crum E; Horvath N
    Prog Clin Biol Res; 1994; 389():463-70. PubMed ID: 7535455
    [No Abstract]   [Full Text] [Related]  

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
    Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.
    Warkentin PI; Jackson JD; Letheby B; Kessinger A
    Prog Clin Biol Res; 1994; 389():643-7. PubMed ID: 7700931
    [No Abstract]   [Full Text] [Related]  

  • 16. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
    Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D
    Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457
    [No Abstract]   [Full Text] [Related]  

  • 19. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
    Ke X; Yang Y; Zhao X; Wang L
    Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.